Astellas Launches Regnite For Moderate To Severe Restless Legs Syndrome
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharmaceuticals announced on July 9 that it will launch Regnite tablets (gabapentin enacarbil) for moderate to severe restless leg syndrome beginning July 10.